Terms: = Liver cancer AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL
46 results:
1. Nonchromosomal birth defects and risk of childhood acute leukemia: An assessment in 15 000 leukemia cases and 46 000 controls from the Childhood cancer and Leukemia International Consortium.
Lupo PJ; Chambers TM; Mueller BA; Clavel J; Dockerty JD; Doody DR; Erdmann F; Ezzat S; Filippini T; Hansen J; Heck JE; Infante-Rivard C; Kang AY; Magnani C; Malagoli C; Marcotte EL; Metayer C; Bailey HD; Mora AM; Ntzani E; Petridou ET; Pombo-de-Oliveira MS; Rashed WM; Roman E; Schüz J; Wesseling C; Spector LG; Scheurer ME
Int J Cancer; 2024 Feb; 154(3):434-447. PubMed ID: 37694915
[TBL] [Abstract] [Full Text] [Related]
2. Small extrachromosomal circular DNAs as biomarkers for multi-cancer diagnosis and monitoring.
Luo X; Zhang L; Cui J; An Q; Li H; Zhang Z; Sun G; Huang W; Li Y; Li C; Jia W; Zou L; Zhao G; Xiao F
Clin Transl Med; 2023 Sep; 13(9):e1393. PubMed ID: 37649244
[TBL] [Abstract] [Full Text] [Related]
3. Design, synthesis and biological evaluation of indazole derivatives as selective covalent inhibitors of FGFR4 in wild-type and gatekeeper mutants.
Yang Y; He X; Li Z; Ran K; Wang N; Zhao L; Liu Z; Zeng J; Chang B; Feng Q; Zhang Q; Yu L
Eur J Med Chem; 2023 Oct; 258():115628. PubMed ID: 37437349
[TBL] [Abstract] [Full Text] [Related]
4. Aberrant MNX1 expression associated with t(7;12)(q36;p13) pediatric acute myeloid leukemia induces the disease through altering histone methylation.
Waraky A; Östlund A; Nilsson T; Weichenhan D; Lutsik P; Bähr M; Hey J; Tunali G; Adamsson J; Jacobsson S; Morsy MHA; Li S; Fogelstrand L; Plass C; Palmqvist L
Haematologica; 2024 Mar; 109(3):725-739. PubMed ID: 37317878
[TBL] [Abstract] [Full Text] [Related]
5. Progression in Myeloid Neoplasms: Beyond the Myeloblast.
Faria C; Tzankov A
Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015
[TBL] [Abstract] [Full Text] [Related]
6. Elaboration of NTRK-rearranged colorectal cancer: Integration of immunoreactivity pattern, cytogenetic identity, and rearrangement variant.
Wu S; Liu Y; Shi X; Zhou W; Zeng X
Dig Liver Dis; 2023 Dec; 55(12):1757-1764. PubMed ID: 37142453
[TBL] [Abstract] [Full Text] [Related]
7. Regorafenib compared to nivolumab after sorafenib failure in patients with hepatocellular carcinoma: A systematic review and meta-analysis.
Yang S; Zhou Y; Zeng L
Adv Clin Exp Med; 2023 Aug; 32(8):839-845. PubMed ID: 37140014
[TBL] [Abstract] [Full Text] [Related]
8. A Two-Step Diagnostic Approach for NTRK Gene Fusion Detection in Biliary Tract and Pancreatic Adenocarcinomas.
Demols A; Rocq L; Perez-Casanova L; Charry M; De Nève N; Ramadhan A; Van Campenhout C; De Clercq S; Maris C; Closset J; Lucidi V; Salmon I; D'Haene N
Oncologist; 2023 Jul; 28(7):e520-e525. PubMed ID: 36994874
[TBL] [Abstract] [Full Text] [Related]
9. Primary inflammatory myofibroblastic tumour of the liver: a clinicopathological and genetic study including a subset with etv6::NTRK3 fusion.
Han Q; Zhang Z; He X; Chen M; Pang X; Chen C; Du T; Zhang H
Histopathology; 2023 May; 82(6):925-936. PubMed ID: 36748182
[TBL] [Abstract] [Full Text] [Related]
10. Discovery of 2-Amino-7-sulfonyl-7
Xie W; Yang S; Liang L; Wang M; Zuo W; Lei Y; Zhang Y; Tang W; Lu T; Chen Y; Jiang Y
J Med Chem; 2022 Dec; 65(24):16570-16588. PubMed ID: 36480917
[TBL] [Abstract] [Full Text] [Related]
11. Nutritional Status Is Associated with Prognosis in Patients with Advanced Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab.
Tada T; Kumada T; Hiraoka A; Kariyama K; Tani J; Hirooka M; Takaguchi K; Atsukawa M; Fukunishi S; Itobayashi E; Tsuji K; Tajiri K; Ochi H; Ishikawa T; Yasuda S; Ogawa C; Toyoda H; Hatanaka T; Nishimura T; Kakizaki S; Kawata K; Shimada N; Tada F; Nouso K; Tsutsui A; Ohama H; Morishita A; Nagano T; Itokawa N; Okubo T; Arai T; Kosaka H; Imai M; Naganuma A; Nakamura S; Koizumi Y; Matono T; Kaibori M; Iijima H; Hiasa Y; ;
Oncology; 2023; 101(4):270-282. PubMed ID: 36455517
[TBL] [Abstract] [Full Text] [Related]
12. Secretory carcinoma of the salivary gland, a rare entity: An international multi-institutional study.
Wiles AB; Gabrielson M; Baloch ZW; Faquin WC; Jo VY; Callegari F; Kholova I; Song S; Centeno BA; Ali SZ; Tommola S; Fadda G; Petrone G; Wang H; Rossi ED; Pantanowitz L; Maleki Z
Cancer Cytopathol; 2022 Sep; 130(9):684-694. PubMed ID: 35385604
[TBL] [Abstract] [Full Text] [Related]
13. Anti-cancer effects of 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivatives on hepatocellular carcinoma harboring FGFR4 activation.
Nam Y; Shin I; Kim Y; Ryu S; Kim N; Ju E; Sim T
Neoplasia; 2022 Jan; 24(1):34-49. PubMed ID: 34864570
[TBL] [Abstract] [Full Text] [Related]
14. Secretory breast carcinoma in a female adult with liver metastsis: a case report and literature review.
Lian J; Wang LX; Guo JH; Bu P; Xi YF; Yun KM
Diagn Pathol; 2021 Oct; 16(1):89. PubMed ID: 34629079
[TBL] [Abstract] [Full Text] [Related]
15. Fetal Mediastinal Fibrosarcoma. Report of Two Cases.
Cagan M; Yildirim S; Turkmen GG; Ozyuncu O; Akcoren Z; Deren O; Gucer S
Fetal Pediatr Pathol; 2022 Oct; 41(5):843-851. PubMed ID: 34622726
[No Abstract] [Full Text] [Related]
16. Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation.
Honda T; Yamaoka M; Terao YM; Hasegawa D; Kumamoto T; Takagi M; Yoshida K; Ogawa S; Goto H; Akiyama M
Int J Hematol; 2022 Jan; 115(1):140-145. PubMed ID: 34591292
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic factors of patients after liver cancer surgery: Based on Surveillance, Epidemiology, and End Results database.
Liang F; Ma F; Zhong J
Medicine (Baltimore); 2021 Jul; 100(30):e26694. PubMed ID: 34397696
[TBL] [Abstract] [Full Text] [Related]
18. Recombinant Expression of Cec-B Peptide in Escherichia coli with a Significant Anticancer Effect on Hepatocellular Carcinoma.
Okasha H; Nasr SM; Samir S
Curr Pharm Biotechnol; 2021; 22(9):1235-1245. PubMed ID: 33397234
[TBL] [Abstract] [Full Text] [Related]
19. Myeloid neoplasm with the abnormality of PDGFRB gene secondary interstitial pneumonia: A case report.
Liu G; Ouyang R; Chen P; Liu T; Zhou L; Shen C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Mar; 45(3):345-348. PubMed ID: 32386029
[TBL] [Abstract] [Full Text] [Related]
20. A novel etv6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma.
Guo C; Gao C; Zhao D; Li J; Wang J; Sun X; Liu Q; Hao L; Greenaway FT; Tian Y; Liu S; Sun MZ
J Exp Clin Cancer Res; 2020 Apr; 39(1):70. PubMed ID: 32326970
[TBL] [Abstract] [Full Text] [Related]
[Next]
